Stockscreener 앱 받기
0.00
100.00%
-0.2001
시간 외 거래:
.18
0.18
+
Unity Biotechnology Inc 주식(UBX)의 최신 뉴스
Unity Biotechnology Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia
What drives Unity Biotechnology Inc. stock priceFree Bull & Bear Market Updates - PrintWeekIndia
Published on: 2025-07-25 18:10:37 - Autocar Professional
Why Unity Biotechnology Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser
What analysts say about Unity Biotechnology Inc. stockOverwhelming financial success - PrintWeekIndia
UBX issues 1 share with 600M votes to speed dissolution plan | UBX SEC FilingForm 8-K/A - Stock Titan
Is Unity Biotechnology Inc. a good long term investmentAccelerated wealth building - Autocar Professional
Unity Biotechnology Alters Voting Dynamics with New Stock - TipRanks
How Unity Biotechnology Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser
Diabetic Macular Edema Pipeline 2025: MOA, ROA, FDA-Approved Drugs, And Clinical Trial Progress Assessment By Delveinsight Oxurion, Ocuphire Pharma, YD Life Science, Unity Biotechnology, Novartis - MenaFN
Diabetic Macular Edema Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Oxurion, Ocuphire Pharma, YD Life Science, Unity Biotechnology, Novartis - The Globe and Mail
What makes Unity Biotechnology Inc. stock price move sharplyFree Access to Investment Community - Newser
Unity Biotechnology, Inc.(NasdaqGS: UBX) dropped from S&P TMI Index - MarketScreener
New Options Listings and Delistings for July 9th: DTCBD, ECG, EMA, UNBX, DTCB, AKYA, UBX - AInvest
Unity Biotechnology Plunges 11.08% Amid Clinical Trial Closure, Nasdaq Delisting - AInvest
Unity Biotechnology stock plunges after Nasdaq delisting notice By Investing.com - Investing.com India
Unity Biotechnology Faces Nasdaq Delisting and Leadership Changes - TipRanks
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution - TradingView
Future of Aging: Longevity & Anti-senescence Therapy Market to Reach $44.2 Billion by 2030 with 6.1% CAGR - newstrail.com
Unity Biotechnology Faces Nasdaq Delisting Notice - TipRanks
Biotech company once valued at $700 million slashes entire workforce - MSN
Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
HC Wainwright Issues Optimistic Forecast for UBX Earnings - Defense World
Unity Biotechnology stock hits 52-week low at $0.66 - Investing.com
Unity Biotechnology stock hits 52-week low at $0.66 By Investing.com - Investing.com India
HC Wainwright & Co. Downgrades Unity Biotechnology (LSE:0YC0) - Nasdaq
Unity Biotechnology (NASDAQ:UBX) Receives Neutral Rating from HC Wainwright - Defense World
0.97%
0.22%
자본화:
|
볼륨(24시간):